Table of Contents

Invited Review

Select this article
- Daniel Medina
Mammary developmental fate and breast cancer risk
Endocr Relat Cancer 12 (3) 483-495, doi:10.1677/erc.1.00804
Select this article
- S A Khan,
- D Bhandare,
- and R T Chatterton, Jr
The local hormonal environment and related biomarkers in the normal breast
Endocr Relat Cancer 12 (3) 497-510, doi:10.1677/erc.1.00732
Select this article
- K-M Rau,
- H-Y Kang,
- T-L Cha,
- S A Miller,
- and M-C Hung
The mechanisms and managements of hormone-therapy resistance in breast and prostate cancers
Endocr Relat Cancer 12 (3) 511-532, doi:10.1677/erc.1.01026
Select this article
- E M Rosen,
- S Fan,
- and C Isaacs
BRCA1 in hormonal carcinogenesis: basic and clinical research
Endocr Relat Cancer 12 (3) 533-548, doi:10.1677/erc.1.00972
Select this article
- G A Clines and
- T A Guise
Hypercalcaemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to bone
Endocr Relat Cancer 12 (3) 549-583, doi:10.1677/erc.1.00543
Select this article
- R Nawar and
- D Aron
Adrenal incidentalomas — a continuing management dilemma
Endocr Relat Cancer 12 (3) 585-598, doi:10.1677/erc.1.00951

Original Research

Select this article
- T Frogne,
- J S Jepsen,
- S S Larsen,
- C K Fog,
- B L Brockdorff,
- and A E Lykkesfeldt
Antiestrogen-resistant human breast cancer cells require activated Protein Kinase B/Akt for growth
Endocr Relat Cancer 12 (3) 599-614, doi:10.1677/erc.1.00946
Select this article
- W-B Zhong,
- Y-C Liang,
- C-Y Wang,
- T-C Chang,
- and W-S Lee
Lovastatin suppresses invasiveness of anaplastic thyroid cancer cells by inhibiting Rho geranylgeranylation and RhoA/ROCK signaling
Endocr Relat Cancer 12 (3) 615-629, doi:10.1677/erc.1.01012
Select this article
- T L Veveris-Lowe,
- M G Lawrence,
- R L Collard,
- L Bui,
- A C Herington,
- D L Nicol,
- and J A Clements
Kallikrein 4 (hK4) and prostate-specific antigen (PSA) are associated with the loss of E-cadherin and an epithelial-mesenchymal transition (EMT)-like effect in prostate cancer cells
Endocr Relat Cancer 12 (3) 631-643, doi:10.1677/erc.1.00958
Select this article
- A Garolla,
- A Ferlin,
- C Vinanzi,
- A Roverato,
- G Sotti,
- W Artibani,
- and C Foresta
Molecular analysis of the androgen receptor gene in testicular cancer
Endocr Relat Cancer 12 (3) 645-655, doi:10.1677/erc.1.00954
Select this article
- Alfredo Berruti,
- Massimo Terzolo,
- Paola Sperone,
- Anna Pia,
- Silvia Della Casa,
- David J Gross,
- Carlo Carnaghi,
- Paolo Casali,
- Francesco Porpiglia,
- Franco Mantero,
- Giuseppe Reimondo,
- Alberto Angeli,
- and Luigi Dogliotti
Etoposide, doxorubicin and cisplatin plus mitotane in the treatment of advanced adrenocortical carcinoma: a large prospective phase II trial
Endocr Relat Cancer 12 (3) 657-666, doi:10.1677/erc.1.01025
Select this article
- D E Schteingart,
- G M Doherty,
- P G Gauger,
- T J Giordano,
- G D Hammer,
- M Korobkin,
- and F P Worden
Management of patients with adrenal cancer: recommendations of an international consensus conference
Endocr Relat Cancer 12 (3) 667-680, doi:10.1677/erc.1.01029

Errata

Select this article

Erratum 1
Endocr Relat Cancer 12 (3) 681, doi:10.1677/erc.1.00973e
Select this article

Erratum 2
Endocr Relat Cancer 12 (3) 682, doi:10.1677/erc.1.00861e

Endocrine-Related Cancer

Invited Review

Mammary developmental fate and breast cancer risk

The local hormonal environment and related biomarkers in the normal breast

The mechanisms and managements of hormone-therapy resistance in breast and prostate cancers

BRCA1 in hormonal carcinogenesis: basic and clinical research

Hypercalcaemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to bone

Adrenal incidentalomas — a continuing management dilemma

Original Research

Antiestrogen-resistant human breast cancer cells require activated Protein Kinase B/Akt for growth

Lovastatin suppresses invasiveness of anaplastic thyroid cancer cells by inhibiting Rho geranylgeranylation and RhoA/ROCK signaling

Kallikrein 4 (hK4) and prostate-specific antigen (PSA) are associated with the loss of E-cadherin and an epithelial-mesenchymal transition (EMT)-like effect in prostate cancer cells

Molecular analysis of the androgen receptor gene in testicular cancer

Etoposide, doxorubicin and cisplatin plus mitotane in the treatment of advanced adrenocortical carcinoma: a large prospective phase II trial

Management of patients with adrenal cancer: recommendations of an international consensus conference

Errata

Erratum 1

Erratum 2

This Issue

New Articles: issue in progress

Most

Viewed

Cited